Subtype
Bladder Neoplasm
CI-CAN-00001978Explore in graph →
Non-malignant390 active trials10 approved drugs25 evidence items
Loading cancer entity…
Subtype
CI-CAN-00001978Explore in graph →
Clinical trials
1,702 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03390127 | Effect of PEEP on Arterial Oxygen Partial Pressure in Elderly Patients With Lithotomy Position Using LMA Supreme™ | completed | N/A | 68 | Asan Medical CenterOTHER | 1 | Apr 6, 2018 | clinicaltrials |
| NCT02977143 | Positive End-expiratory Pressure-induced Increase in Central Venous Pressure as a Predictor of Fluid Responsiveness in Robot-assisted Laparoscopic Surgery | completed | N/A | 50 | Seoul National University HospitalOTHER | 1 | Apr 3, 2018 |
| NCT01836978 | Prehabilitation to Enhance Postoperative Functional Capacity Following Radical Cystectomy | completed | N/A | 70 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Mar 22, 2018 | clinicaltrials |
| NCT02214602 | Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer(NMIBCIVT) | completed | Phase 4 | 240 | Mansoura UniversityOTHER | 1 | Mar 22, 2018 | clinicaltrials |
| NCT01259063 | RAD001 and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Carcinoma In Situ of the Bladder | completed | Phase 1 / Phase 2 | 33 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 13, 2018 | clinicaltrials |
| NCT01637935 | Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes | completed | — | 193,099 | TakedaINDUSTRY | 0 | Mar 7, 2018 | clinicaltrials |
| NCT01446822 | Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors | completed | N/A | 44 | Daniel Stephan EngelerOTHER | 1 | Mar 5, 2018 | clinicaltrials |
| NCT02328417 | Enhanced Recovery After Radical Cystectomy Study | completed | — | 241 | Carlos LlorenteOTHER | 1 | Feb 22, 2018 | clinicaltrials |
| NCT01090466 | Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium | completed | Phase 1 / Phase 2 | 15 | Cardiff UniversityOTHER | 1 | Feb 6, 2018 | clinicaltrials |
| NCT01215071 | Eingeschränkte vs Ausgedehnte Lymphadenektomie LEA | completed | N/A | 401 | Association of Urologic Oncology (AUO)OTHER | 1 | Jan 24, 2018 | clinicaltrials |
| NCT00461851 | Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma | completed | Phase 2 | 17 | Yale UniversityOTHER | 1 | Dec 14, 2017 | clinicaltrials |
| NCT01567462 | PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors(PK Button) | completed | N/A | 95 | Emory UniversityOTHER | 1 | Dec 8, 2017 | clinicaltrials |
| NCT00666562 | Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer | completed | Phase 2 | 31 | National Cancer Institute (NCI)NIH | 1 | Nov 17, 2017 | clinicaltrials |
| NCT02993497 | Respiratory Measurement Using Infrared Camera and Respiratory Volume Monitor (ExSpiron 1Xi) for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia | completed | N/A | 20 | Yonsei UniversityOTHER | 1 | Nov 14, 2017 | clinicaltrials |
| NCT00598806 | Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612) | completed | Phase 3 | 812 | Spectrum Pharmaceuticals, IncINDUSTRY | 3 | Nov 13, 2017 | clinicaltrials |
| NCT00666978 | Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking | completed | Phase 4 | 540 | Lisa Sanderson Cox, PhDOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT01938573 | Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer | completed | Phase 1 / Phase 2 | 21 | University of WashingtonOTHER | 1 | Oct 20, 2017 | clinicaltrials |
| NCT02106416 | Use of PET/MRI Tracer to Further Understanding of Prostate Cancer Development | completed | N/A | 21 | NYU Langone HealthOTHER | 1 | Oct 11, 2017 | clinicaltrials |
| NCT01955408 | Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment(OABSYNERGO) | completed | — | 35 | Meir Medical CenterOTHER | 1 | Oct 6, 2017 | clinicaltrials |
| NCT02655081 | Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystectomy(IMPACT) | completed | Phase 2 | 48 | University of PittsburghOTHER | 1 | Oct 3, 2017 | clinicaltrials |
| NCT00318266 | NMP22 Provides Improved Sensitivity in Detecting Bladder Cancers. | completed | — | 73 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Aug 25, 2017 | clinicaltrials |
| NCT02001857 | Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer. | completed | Phase 4 | 200 | University Hospital, GhentOTHER | 1 | Aug 25, 2017 | clinicaltrials |
| NCT02852564 | Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection | completed | Phase 1 | 12 | Eugene Lee, MDOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT02287701 | Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization | completed | N/A | 24 | NYU Langone HealthOTHER | 1 | Aug 14, 2017 | clinicaltrials |
| NCT01915121 | An Educational Intervention for Patients With Bladder Cancer | completed | N/A | 43 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Aug 4, 2017 | clinicaltrials |
| NCT02080650 | Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) | completed | N/A | 62 | Duke UniversityOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT02039310 | Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical Cystectomy | completed | — | 59 | University of MichiganOTHER | 1 | Jul 27, 2017 | clinicaltrials |
| NCT01687244 | Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer | completed | Phase 2 | 40 | FKD Therapies OyINDUSTRY | 0 | Jul 24, 2017 | clinicaltrials |
| NCT00380029 | Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer | completed | Phase 2 | 27 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jul 19, 2017 | clinicaltrials |
| NCT01015963 | Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871 | completed | — | 69 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 13, 2017 | clinicaltrials |
| NCT00330499 | Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer. | completed | Phase 3 | 67 | Trans Tasman Radiation Oncology GroupOTHER | 2 | Jul 12, 2017 | clinicaltrials |
| NCT01236053 | Cancer in Patients With Gabapentin (GPRD) | completed | — | 2,323,608 | GlaxoSmithKlineINDUSTRY | 0 | Jul 6, 2017 | clinicaltrials |
| NCT02465892 | Pillars4Life Trial(Pillars4Life) | completed | N/A | 284 | Duke UniversityOTHER | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01803295 | Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC(OPTIMA) | completed | N/A | 80 | UroGen Pharma Ltd.INDUSTRY | 4 | Jun 16, 2017 | clinicaltrials |
| NCT02307487 | Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients | completed | Phase 2 | 14 | UroGen Pharma Ltd.INDUSTRY | 1 | Jun 16, 2017 | clinicaltrials |
| NCT02778243 | Sexual Steroids: Relationship Between Serum and Prostatic Tissue Level(STERPROSER) | completed | N/A | 107 | Hopital FochOTHER | 1 | Jun 14, 2017 | clinicaltrials |
| NCT01108055 | Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer | completed | Phase 2 | 43 | Sandy SrinivasOTHER | 1 | Jun 9, 2017 | clinicaltrials |
| NCT03174912 | In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both? | completed | Phase 4 | 400 | Ankara Training and Research HospitalOTHER | 0 | Jun 5, 2017 | clinicaltrials |
| NCT02738827 | Diode Laser Treatment of Bladder Tumors | completed | N/A | 21 | Gregers Gautier HermannOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT00376987 | Zinc Supplements in Lowering Cadmium Levels in Smokers | completed | Phase 2 | 61 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00534001 | Bupropion in Helping Adults Stop Smoking | completed | Phase 2 | 95 | Roswell Park Cancer InstituteOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00004095 | Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 38 | Northwestern UniversityOTHER | 1 | Apr 18, 2017 | clinicaltrials |
| NCT02050451 | Perioperative Oral Nutrition Intervention for Patients Undergoing Radical Cystectomy | completed | N/A | 60 | Vanderbilt UniversityOTHER | 1 | Mar 29, 2017 | clinicaltrials |
| NCT01444456 | Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia | completed | — | 1,262 | AmgenINDUSTRY | 9 | Mar 20, 2017 | clinicaltrials |
| NCT00957424 | Acceptability of Less Harmful Alternatives to Cigarettes | completed | N/A | 67 | Roswell Park Cancer InstituteOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT01828736 | Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma(CVH-CT02) | completed | Phase 2 | 61 | Association Pour La Recherche des Thérapeutiques Innovantes en CancérologieOTHER | 2 | Feb 6, 2017 | clinicaltrials |
| NCT02326168 | PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer | completed | Early Phase 1 | 25 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT01142102 | Feasibility of Online Adaptive Radiotherapy for Muscle Invasive Bladder Cancer(BOLART) | completed | N/A | 50 | Trans Tasman Radiation Oncology GroupOTHER | 2 | Jan 24, 2017 | clinicaltrials |
| NCT00003657 | High-dose ICE With Amifostine | completed | Phase 2 | 24 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 20, 2017 | clinicaltrials |
| NCT00578006 | Internet-based System for Cancer Patients to Self-report Toxicity | completed | N/A | 1,007 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 10, 2017 | clinicaltrials |
Data updated 24 days agoSource updated Apr 6, 2018source: clinicaltrials